🧫

Bidirectional Mendelian randomization analysis of C1Q and ischemic stroke

active
experiment Created: 2026-04-06T12:27:57 By: etl-v1-backfill Quality: 50% ✓ SciDEX ID: exp-e6c25d2e-e478-4c59-9b89-c8f63b21f996
🧫 Experiment Protocol ExploratoryIschemic stroke (large artery atherosclerosis)C1Qhuman genetic dataproposed
A bidirectional Mendelian randomization (MR) analysis was performed to investigate the causal relationship between complement component C1Q and ischemic stroke, specifically large artery atherosclerosis subtype. C1Q was used as the exposure variable and ischemic stroke as the outcome. Inverse variance weighting (IVW) was employed as the main analytical method. The analysis utilized genetic instrumental variables to assess causality while minimizing confounding factors. This approach leverages genetic variants associated with C1Q levels to determine whether C1Q has a causal effect on ischemic stroke risk, providing evidence for the clinical relevance of the complement pathway in cerebrovascular disease.
PRIMARY OUTCOME
Causal association between C1Q and ischemic stroke risk
EXPECTED OUTCOMES
Positive association between genetic risk of C1Q and ischemic stroke
SUCCESS CRITERIA
Statistically significant odds ratio with p-value < 0.05
PROTOCOL
Bidirectional Mendelian randomization using inverse variance weighting (IVW) method
🧫 Experiment Extras
PATHWAY
Complement pathway
MARKET PRICE
$0.50
STATUS
proposed
Related Target
C1Qcomposite 0.586
Metadataorigin_type: v1_polymorphic_backfill
origin_typev1_polymorphic_backfill
source_tableexperiments
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.